430
Participants
Start Date
October 31, 2005
Primary Completion Date
September 30, 2007
Study Completion Date
September 30, 2007
GW274150
The tablets used in this study will contain either 5mg or 30mg of GW274150
Placebo
Placebo to Match GW274150
GSK Investigational Site, Antwerp
GSK Investigational Site, Hamar
GSK Investigational Site, Elverum
GSK Investigational Site, Leuven
GSK Investigational Site, Lier
GSK Investigational Site, Oelstykke
GSK Investigational Site, Liège
GSK Investigational Site, Odense C
GSK Investigational Site, Bergen
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Genoa
GSK Investigational Site, Sestri Ponente (GE)
GSK Investigational Site, Turku
GSK Investigational Site, Kiel
GSK Investigational Site, Évreux
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Toulouse
GSK Investigational Site, Feltre (BL)
GSK Investigational Site, Oviedo
GSK Investigational Site, Tampere
GSK Investigational Site, Hüttenberg
GSK Investigational Site, Tours
GSK Investigational Site, Luynes
GSK Investigational Site, Voiron
GSK Investigational Site, Jyväskylä
GSK Investigational Site, Modena
GSK Investigational Site, Montbrison
GSK Investigational Site, Essen
GSK Investigational Site, Valencia
GSK Investigational Site, Münster
GSK Investigational Site, Mikkeli
GSK Investigational Site, Florence
GSK Investigational Site, Lille
GSK Investigational Site, Anzin
GSK Investigational Site, Vieux-Condé
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Weinheim
GSK Investigational Site, Chilly-Mazarin
GSK Investigational Site, Catania
GSK Investigational Site, Glostrup Municipality
GSK Investigational Site, Helsinki
GSK Investigational Site, Rome
GSK Investigational Site, Blaricum
GSK Investigational Site, Eindhoven
GSK Investigational Site, Etten-Leur
GSK Investigational Site, Geldermalsen
GSK Investigational Site, Grubbenvorst
GSK Investigational Site, Heerlen
GSK Investigational Site, Hengelo
GSK Investigational Site, Hoogwoud
GSK Investigational Site, Nijmegen
GSK Investigational Site, Spijkenisse
GSK Investigational Site, Venray
GSK Investigational Site, Zwolle
GSK Investigational Site, Hønefoss
GSK Investigational Site, Oslo
GSK Investigational Site, Sandvika
GSK Investigational Site, Ávila
GSK Investigational Site, Barcelona
Lead Sponsor
GlaxoSmithKline
INDUSTRY